Mimedx Group Inc (MDXG) 7.71 $MDXG MiMedx Announces

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mimedx Group Inc (MDXG) 7.71 $MDXG

MiMedx Announces Second Quarter 2016 Results
PR Newswire - Tue Jul 26, 6:30AM CDT
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today its results for the second quarter of 2016.
MDXG: 7.71 (+0.22)

MiMedx Announces Nationwide Launch of New Ambient Temperature Version of OrthoFlo
PR Newswire - Mon Jul 25, 6:30AM CDT
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today its expansion of its regenerative medicine portfolio with plans for the nationwide launch of the Company's next generation new lyophilized version of OrthoFlo.
MDXG: 7.71 (+0.22)

MiMedx Second Quarter Of 2016 Revenue Exceeds Upper End Of Guidance Range
PR Newswire - Mon Jul 11, 4:55PM CDT
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today its revenue results for the second quarter of 2016.
MDXG: 7.71 (+0.22)

MiMedx Adds New Executive
PR Newswire - Thu Jul 07, 7:30AM CDT
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today that Dr. I. Mark Landy has joined MiMedx as the Company's Vice President responsible for key strategic initiatives.
MDXG: 7.71 (+0.22)

MiMedx Reaches Settlement With Medline Industries And Liventa Bioscience For Certain Claims
PR Newswire - Tue Jun 21, 11:00AM CDT
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today that the Company has agreed to terms of settlement with each of Medline Industries, Inc. ("Medline" and Liventa Bioscience, Inc. ("Liventa" for false advertising claims asserted against each of them by MiMedx.
MDXG: 7.71 (+0.22)

Independent Clinical Case Series Demonstrates MiMedx dHACM, Along With Split Thickness Skin Grafts, Is Effective In Limb Salvage
PR Newswire - Wed Jun 01, 4:43PM CDT
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today that the most recent peer-reviewed independent clinical case series of MiMedx EpiFix® allografts has been published. The paper, "Bone and Tendon Coverage via Dehydrated Human Amniotic/Chorionic Membrane and Split-Thickness Skin Grafting," was electronically published in the Journal of Reconstructive Microsurgery.
MDXG: 7.71 (+0.22)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Possible Securities Fraud Violations by Certain Officers and Directors of Osiris Therapeutics, Inc. -- OSIR
BusinessWire - Wed Jun 01, 10:08AM CDT
Levi & Korsinsky announces it has commenced an investigation of Osiris Therapeutics, Inc. ("Osiris Therapeutics" or the "Company" (NASDAQ: OSIR) concerning possible violations of federal securities laws.
OSIR: 5.05 (+0.05), MDXG: 7.71 (+0.22)

MiMedx To Present At The Jefferies 2016 Global Healthcare Conference
PR Newswire - Thu May 26, 1:00PM CDT
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic membrane and other birth tissues, human skin and bone, and patent-protected processes and proprietary platforms to develop and market advanced products and therapies, announced today that it will present at the Jefferies 2016 Global Healthcare Conference in New York, New York. Parker H. "Pete" Petit, Chairman and CEO, Michael J. Senken, Chief Financial Officer, and Christopher M. Cashman, EVP and Chief Commercialization Officer, are scheduled to present on Wednesday, June 8th at 4:30 p.m. eastern time, at the Grand Hyatt New York. A webcast of this presentation will be available on the Company's website, www.mimedx.com.
MDXG: 7.71 (+0.22)

MiMedx to Attend the 13th Annual Craig-Hallum Institutional Investor Conference
PR Newswire - Mon May 23, 8:30AM CDT
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic membrane and other birth tissues, human skin and bone, and patent-protected processes and proprietary platforms to develop and market advanced products and therapies, announced today that it will attend the 13th Annual Craig-Hallum Institutional Investor Conference in Minneapolis, Minnesota. Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO, and Michael J. Senken, Chief Financial Officer, are scheduled to participate in one-on-one and small group meetings on Wednesday, June 1, 2016, at The Depot Renaissance Minneapolis Hotel.
MDXG: 7.71 (+0.22)

MiMedx Provides Reminder of May 18th Annual Shareholders Meeting
PR Newswire - Tue May 17, 12:15PM CDT
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, provided a reminder for the Company's Annual Shareholder meeting tomorrow, May 18, 2016, as well as a reminder that the annual meeting will be at the newer MiMedx facility located at 1828 West Oak Parkway, Marietta, Georgia. This facility is in the same business park as the MiMedx corporate headquarters and is located near the middle of the business park approximately one-half mile from the Company's main office.
MDXG: 7.71 (+0.22)

MiMedx Files Lawsuit Against Osiris For False And Misleading Representations
PR Newswire - Tue May 17, 7:30AM CDT
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today that it has filed a lawsuit under the Lanham Act against Osiris Therapeutics, Inc. for permanent injunctive relief and damages.
OSIR: 5.05 (+0.05), MDXG: 7.71 (+0.22)

MiMedx to Present at the UBS 2016 Global Healthcare Conference
PR Newswire - Mon May 16, 8:30AM CDT
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic membrane and other birth tissues, human skin and bone, and patent-protected processes and proprietary platforms to develop and market advanced products and therapies, announced today that it will present at the UBS 2016 Global Healthcare Conference in New York, NY. Parker H. "Pete" Petit, Chairman and CEO, Michael J. Senken, Chief Financial Officer, and Christopher M. Cashman, EVP and Chief Commercialization Officer, are scheduled to present on Tuesday, May 24, 2016 at 10:30 a.m. eastern time, at the Grand Hyatt New York. A webcast of this presentation will be available on the Company's website, www.mimedx.com.
MDXG: 7.71 (+0.22)

MiMedx Comments on Flawed Osiris Data Review
PR Newswire - Tue May 03, 8:04AM CDT
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, responded today to highlight the substantive deficiencies and serious flaws in a recent data review reported by Osiris Therapeutics, Inc.
MDXG: 7.71 (+0.22)

MiMedx To Present At The 41st Annual Deutsche Bank Securities Healthcare Conference
PR Newswire - Thu Apr 28, 10:00AM CDT
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic membrane and other birth tissues, human skin and bone, and patent-protected processes and proprietary platforms to develop and market advanced products and therapies, announced today that it will participate in the 41st Annual Deutsche Bank Securities Healthcare Conference in Boston, Massachusetts. Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO, and Michael J. Senken, Chief Financial Officer, are scheduled to participate on Thursday, May 5, 2016 at 10:00 a.m. eastern time, at the InterContinental Hotel. A webcast of this presentation will be available on the Company's website, www.mimedx.com.
DB: 13.07 (-0.37), MDXG: 7.71 (+0.22)

MiMedx Announces First Quarter 2016 Results
PR Newswire - Mon Apr 25, 7:13PM CDT
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today its results for the first quarter of 2016.
MDXG: 7.71 (+0.22)

MiMedx Announces Release Date for 2016 First Quarter Results
PR Newswire - Tue Apr 19, 8:00AM CDT
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic membrane and other birth tissues, human skin and bone, and patent-protected processes and proprietary platforms to develop and market advanced products and therapies, announced today that its results for the first quarter ended March 31, 2016, will be released before the opening of the market on Tuesday, April 26, 2016. MiMedx will host a live broadcast of its first quarter conference call on Tuesday, April 26, 2016, at 10:30 a.m. Eastern Time. A listen-only simulcast of the MiMedx conference call will be available online at the Company's website, www.mimedx.com. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast. The replay can also be found on the Company's website at www.mimedx.com.
MDXG: 7.71 (+0.22)

The Impact of MiMedx EpiFix® to be Presented at SAWC Conference
PR Newswire - Tue Apr 12, 12:34PM CDT
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today that nine poster abstracts showing the clinical and cost effective healing results of the Company's Dehydrated Human Amnion/Chorion Membrane (dHACM) allografts will be presented at the 2016 Symposium on Advanced Wound Care and Wound Healing Society (2016 SAWC Spring/WHS) meeting. The symposium is the leading national wound healing conference and is now in its 29th year. The 2016 SAWC Spring/WHS begins April 13, 2016, and concludes on April 17, 2016, and MiMedx will be exhibiting from April 14th through April 16th in booth #615.
MDXG: 7.71 (+0.22)

What Has MiMedx Group Shares Dropping 10% Today?
Todd Campbell, The Motley Fool - Motley Fool - Mon Apr 11, 12:57PM CDT
IMAGE SOURCE: MIMEDX GROUP, INC. What: Following news that first-quarter revenue will be shy of forecasts, shares in MiMedx Group  are tumbling 10% at 1:30 p.m. ET today. So what: MiMedx develops wound-healing technologies from human...
MDXG: 7.71 (+0.22)

MiMedx Announces First Quarter of 2016 Revenue Results
PR Newswire - Sun Apr 10, 4:00PM CDT
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today its revenue results for the first quarter of 2016.
MDXG: 7.71 (+0.22)

5 Stocks with Surging Estimates in Q1 Earnings Season
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 9:03AM CDT
S&P 500 companies are likely to witness a 10.3% year-over-year decline in earnings in the quarter. The 5 mentioned stocks are expected to post earnings growth despite the oddities.
SFE: 12.84 (-0.08), CPN: 13.43 (-0.31), EPZM: 10.35 (-0.01), MDXG: 7.71 (+0.22), AUY: 5.77 (+0.06)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 171

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
Elah Holdings' Q3 2026 Report Sparks Investor Interest

Updated Category News Views 79

Elah Holdings Drops Their Q3 2026 Numbers Eat your heart out, folks—Elah Holdings has just dropped their third quarter report for 2026, and it caught some eyes. This ain't your run-of-the-mill, brush-right-past-it release. They're out there, waving their flag high in the competitive marketplace, trying to tell us they mean business. If you missed the announcement, they...

Continue Reading
Cracking Life Insurance Needs: John Dorsa's Insights

Updated Category News Views 137

Life Insurance: A Necessary Puzzle Life’s uncertainties have a way of putting a wrench in our plans, and nothing screams uncertainty like figuring out life insurance. But fret not! HelloNation’s got insights on this financial maze, and they’ve roped in insurance pro John Dorsa from Ridgeland to help out. Calculating Coverage Needs Forget the one-size-fits-all...

Continue Reading
Choate's Expands to New Mid-South Markets

Updated Category News Views 171

Family Traditions Drive Choate's Growth Back in the day, you might've thought the family-run businesses were a dying breed, right? Not in the case of Choate's Air Conditioning, Heating, Plumbing & Electrical. These folks aren't just holding the fort; they're storming new territories across the Mid-South like they've got something to prove—or maybe just something to...

Continue Reading
Texxon Faces Revenue Slide Amid Strategic Shifts

Updated Category News Views 155

Texxon's Strategic Transitions and Financial Headaches Texxon Holding Limited (NASDAQ:NPT) just laid their cards on the table, unveiling a mixed bag in their fiscal year 2026 results. As the world's chemical and plastics scene faces winds of change, Texxon buckled down and tried to steer the ship clear from the rocks. It's a balancing act juggling market headwinds, a new...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 359

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading
AI Alliance Rethinks Health Plan Engagement

Updated Category News Views 139

Building Bridges in Healthcare Ever seen healthcare stuck in its own muck with disconnected gears attempting to move the same machine? Well, that's precisely the mountain healthplans.ai and URAWARRIOR aim to climb down from. Founders Rachel Spilo and Dr. Bershan Shaw are gearing up to shake hands in their no-nonsense, real-world vow to sync member engagement with the...

Continue Reading
The Melt Grabs Top Spot in Burger Ratings War

Updated Category News Views 122

Burger Battle: The Melt Claims Victory When you're in the cutthroat world of fast-casual dining, grabbing the top spot on any list is no small potatoes. The Melt did just that, snatching the title of America’s Highest-Rated Burger Spot. Based on an in-depth analysis of Google and Yelp reviews, folks have spoken, loud and clear, over the past two years. It's a world...

Continue Reading
Philadelphia Firm Targets 100 Toys for Children This Holiday

Updated Category News Views 0

A hundred unopened toys can look modest on paper, yet that is exactly why this Philadelphia effort lands differently than the usual chest-thumping corporate charity chatter. van der Veen, Hartshorn & Levin has set a clear holiday target: collect 100 new, unwrapped toys for children in the Philadelphia area through the U.S. Marine Corps Reserve Toys for Tots program. No...

Continue Reading
LifeVac's 7,000 Reported Saves Deserve Careful Context

Updated Category News Views 0

Veggie straws are supposed to be harmless until they are not. LifeVac says a 19-month-old girl in South Dakota became unable to breathe on November 14 after eating the snack, with a sticky piece creating a complete airway obstruction. Her father retrieved the family's LifeVac, used the pediatric mask while she was on her back, and the company says one application...

Continue Reading

Top 5 Most Recently Viewed Articles

Epson Robots Unveils Cutting-Edge Automation Tech at Expo

Updated Category News Views 360

Innovative Automation Solutions by Epson Robots Epson Robots is set to showcase its latest high-performance automation solutions at an upcoming major tradeshow. The focus will be on the exciting advancements in the SCARA and 6-Axis robots, which are recognized globally for their efficiency and precision in various industries. Exciting New Product Launches At the event,...

Continue Reading
Rexel Reports Fourth Quarter Growth Amid Market Challenges

Updated Category News Views 313

Rexel's Financial Performance Overview Rexel has released its fourth quarter (Q4) and full year (FY) financial results, showcasing strong performance amid challenging market conditions. The company's FY 2024 sales reached €19,285.1 million, reflecting a modest year-on-year increase of 0.7% on a reported basis. This growth narrative underscores Rexel's effective...

Continue Reading
Monster Beverage Sees Gains in 2025 First Quarter Results

Updated Category News Views 313

Monster Beverage's Impressive First Quarter Growth 2025 First Quarter Highlights The financial landscape for Monster Beverage Corporation (NASDAQ: MNST) revealed compelling growth in the first quarter of 2025. Gross profit as a percentage of net sales improved significantly, reaching 56.5 percent. The company reported an operating income increase of 5.1 percent, totaling...

Continue Reading
Transforming Metastatic HR+/HER2- Breast Cancer Care Innovations

Updated Category News Views 215

Transforming Treatment Strategies for Metastatic HR+/HER2- Breast Cancer In recent years, the landscape of metastatic HR+/HER2- breast cancer treatment has evolved dramatically. With innovative therapies coming to the forefront, patients now have access to a wider range of treatment options that aim to improve survival rates and quality of life. The rise of targeted...

Continue Reading
Oil Price Surge Driven by Manufacturing Growth in China

Updated Category News Views 193

Understanding the Recent Trends in Oil Prices Oil prices experienced an uptick recently, driven by promising signs from China's manufacturing sector. Reports reveal that China's factory activity demonstrated growth in December, marking it as a significant development in the global oil landscape. However, despite this positive news, oil prices are on a trajectory to finish...

Continue Reading